- Companies
- Medanta
Medanta Valuation Multiples
Medanta is valued at $3.4B as of October 2026, a 6.6x revenue multiple. In the last 12 months, Medanta revenue was $517M and Medanta EBITDA was $115M.
Medanta Overview
About Medanta
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
Founded
2004
HQ
Employees
9.7K
Website
Sectors
Financials (LTM)
EV
$3.4B
Valuation Multiples
Start free trialMedanta Financials
Medanta reported last 12-month revenue of $517M and EBITDA of $115M.
In the same LTM period, Medanta generated $402M in gross profit, $115M in EBITDA, and $68M in net income.
Revenue (LTM)
Medanta P&L
In the most recent fiscal year, Medanta reported revenue of $457M and EBITDA of $99M.
Medanta is profitable as of last fiscal year, with gross margin of 77%, EBITDA margin of 22%, and net margin of 13%.
Financial data powered by Morningstar, Inc.
Medanta Stock Performance
Medanta has current market cap of $3.4B, and enterprise value of $3.4B.
Market Cap Evolution
Medanta's stock price is $12.67.
Medanta share price decreased by 11.0% in the last 30 days, and by 14.3% in the last year.
Medanta has an EPS (earnings per share) of $0.22.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.4B | $3.4B | -2.7% | -11.0% | -14.1% | -14.3% | $0.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedanta Valuation Multiples
Medanta trades at 6.6x EV/Revenue multiple, and 29.7x EV/EBITDA.
EV / Revenue (LTM)
Medanta Financial Valuation Multiples
As of October 23, 2026, Medanta has market cap of $3.4B and EV of $3.4B.
Medanta has a P/E ratio of 50.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medanta Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Medanta Margins & Growth Rates
Medanta grew revenue by 23% and EBITDA by 30% in the last fiscal year.
In the most recent fiscal year, Medanta reported gross margin of 77%, EBITDA margin of 22%, and net margin of 13%.
Medanta Margins
Medanta Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Medanta Operational KPIs
Medanta's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Medanta's Rule of 40 is 46% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medanta's Rule of X is 80% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Medanta Competitors
Medanta competitors include Narayana Health, Krishna Institute of Medical Sciences, Acadia Healthcare, Mouwasat, IKS Health, Meinian Onehealth, Asker Healthcare Group, Medicover, Kpj Healthcare and Guardian Pharmacy Service.
Most Medanta public comparables operate across Hospitals & Clinics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $831M | $169M | 4.8x | 3.9x | 23.5x | 19.9x | |||
| $409M | $85M | 8.4x | 7.1x | 40.7x | 33.9x | |||
| $3.3B | ($738M) | 1.7x | 1.6x | (7.6x) | 9.2x | |||
| $859M | $300M | 3.8x | 3.5x | 10.9x | 10.7x | |||
| $338M | $115M | 8.7x | 6.8x | 25.7x | 21.6x | |||
| $1.6B | $307M | 2.2x | 2.3x | 11.4x | 14.9x | |||
| $1.7B | $169M | 2.0x | 1.7x | 19.8x | 13.8x | |||
| $2.7B | $419M | 2.1x | 2.0x | 13.6x | 12.4x | |||
This data is available for Pro users. Sign up to see all Medanta competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medanta
| When was Medanta founded? | Medanta was founded in 2004. |
| Where is Medanta headquartered? | Medanta is headquartered in India. |
| How many employees does Medanta have? | As of today, Medanta has over 9K employees. |
| Who is the CEO of Medanta? | Medanta's CEO is Pankaj Sahni. |
| Is Medanta publicly listed? | Yes, Medanta is a public company listed on Bombay Stock Exchange. |
| What is the stock symbol of Medanta? | Medanta trades under 543654 ticker. |
| When did Medanta go public? | Medanta went public in 2022. |
| Who are competitors of Medanta? | Medanta main competitors include Narayana Health, Krishna Institute of Medical Sciences, Acadia Healthcare, Mouwasat, IKS Health, Meinian Onehealth, Asker Healthcare Group, Medicover, Kpj Healthcare, Guardian Pharmacy Service. |
| What is the current market cap of Medanta? | Medanta's current market cap is $3.4B. |
| What is the current revenue of Medanta? | Medanta's last 12 months revenue is $517M. |
| What is the current revenue growth of Medanta? | Medanta revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of Medanta? | Current revenue multiple of Medanta is 6.6x. |
| What is the current EBITDA of Medanta? | Medanta's last 12 months EBITDA is $115M. |
| What is Medanta's EBITDA margin? | Medanta's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Medanta? | Current EBITDA multiple of Medanta is 29.7x. |
| What is the current FCF of Medanta? | Medanta's last 12 months FCF is $14M. |
| What is Medanta's FCF margin? | Medanta's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Medanta? | Current FCF multiple of Medanta is 238.2x. |
| How many companies Medanta has acquired to date? | Medanta hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Medanta has invested to date? | Medanta hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Medanta
Lists including Medanta
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




